Anti-dsDNA Response After Pulse Cyclophosphamide Therapy, with Early Proteinuria Trend as a Secondary Finding
Annals of International Medical and Dental Research · 2026-08 · 12 (4) · 29-35
DOI: 10.53339/aimdr.2026.12.4.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of International Medical and Dental Research, 2026-08. Verfasst von Md. Raisul Islam und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Lupus nephritis is a major renal manifestation of systemic lupus erythematosus and requires close monitoring of immunological and urinary response after induction therapy. Anti-dsDNA level and proteinuria are commonly used markers of disease activity and treatment response in routine clinical practice.
Objective
To assess anti-dsDNA response after pulse cyclophosphamide therapy among patients with lupus nephritis, with early proteinuria trend as a secondary finding.
Methods
This retrospective observational study was conducted at Khwaja Yunus Ali Medical College & Hospital from July to December 2025 among 34 patients with lupus nephritis or SLE-related renal syndrome receiving pulse cyclophosphamide therapy. Clinical features, anti-dsDNA levels, and proteinuria grades were analyzed. Data were expressed as frequency, percentage, median, and interquartile range, with paired non-parametric tests used for analysis. A P-value
Zitieren
APA
Islam, M. R., Islam, M. I., & Hasan, M. (2026). Anti-dsDNA Response After Pulse Cyclophosphamide Therapy, with Early Proteinuria Trend as a Secondary Finding. Annals of International Medical and Dental Research, 12(4), 29-35. https://doi.org/10.53339/aimdr.2026.12.4.5
Vancouver
Islam MR, Islam MI, Hasan M. Anti-dsDNA Response After Pulse Cyclophosphamide Therapy, with Early Proteinuria Trend as a Secondary Finding. Annals of International Medical and Dental Research. 2026;12(4):29-35. doi:10.53339/aimdr.2026.12.4.5
BibTeX
@article{Islam2026,
author = {Islam, Md. Raisul and Islam, Md. Imtiazul and Hasan, Mehedi},
title = {Anti-dsDNA Response After Pulse Cyclophosphamide Therapy, with Early Proteinuria Trend as a Secondary Finding},
journal = {Annals of International Medical and Dental Research},
year = {2026},
volume = {12},
number = {4},
pages = {29--35},
doi = {10.53339/aimdr.2026.12.4.5}
}
EUVIMED